Price Target Changes｜Barclays Lowered Teladoc Health to $77;Telsey Cut Home Depot to $375
Benzinga2022-02-23
- Barclays lowered Teladoc Health, Inc. price target from $95 to $77. Teladoc Health shares dropped 2.3% to $63.81 in pre-market trading.
- JP Morgan boosted the price target on Palo Alto Networks, Inc. from $600 to $620. Palo Alto shares jumped 7.6% to $511.71 in pre-market trading.
- BMO Capital lowered the price target for Rackspace Technology, Inc. from $18 to $10.5. Rackspace Technology shares fell 24.6% to $8.18 in pre-market trading.
- Telsey Advisory Group cut The Home Depot, Inc. price target from $425 to $375. Home Depot shares rose 0.6% to $318.18 in pre-market trading.
- Keybanc cut Tempur Sealy International, Inc. price target from $55 to $46. Tempur Sealy shares rose 1.7% to $30.65 in pre-market trading.
- Piper Sandler raised the price target on Marathon Oil Corporation from $22 to $27. Marathon Oil shares rose 1.2% to $21.86 in pre-market trading.
- HSBC reduced the price target for American Water Works Company, Inc. from $190 to $182. American Water Works shares rose 1.1% to $149.50 in pre-market trading.
- Raymond James cut the price target on Teleflex Incorporated from $391 to $370. Teleflex shares gained 2.1% to close at $322.53 on Tuesday.
- SVB Leerink lowered Agilent Technologies, Inc. price target from $175 to $145. Agilent shares fell 1.2% to close at $130.49 on Tuesday.
- Needham reduced Medtronic plc price target from $128 to $124. Medtronic shares rose 0.6% to $104.38 in pre-market trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
